Article
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.
Molecular neurodegeneration - 8 Aug 2018
Chen Jason A, Chen Zhongbo, Won Hyejung, Huang Alden Y, Lowe Jennifer K, Wojta Kevin, Yokoyama Jennifer S, Bensimon Gilbert, Leigh P Nigel, Payan Christine, Shatunov Aleksey, Jones Ashley R, Lewis Cathryn M, Deloukas Panagiotis, Amouyel Philippe, Tzourio Christophe, Dartigues Jean-Francois, Ludolph Albert, Boxer Adam L, Bronstein Jeff M, Al-Chalabi Ammar, Geschwind Daniel H, Coppola Giovanni
Abstract excerpt
BACKGROUND: Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease for which the genetic contribution is incompletely understood. METHODS: We conducted a joint analysis of 5,523,934 imputed SNPs in two newly-genotyped progressive supranuclear palsy cohorts, primarily derived from two clinical trials (Allon davunetide and NNIPPS riluzole trials in PSP) and a previously published genome-wide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.